Literature DB >> 28523571

Congenital immature pure erythroid leukemia with E-cadherin expression.

Akihiro Tamura1, Suguru Uemura2, Atsuro Saito2, Saki Okubo3, Nanako Nino2, Teppei Tahara2, Takehito Yokoi2, Kenji Kishimoto2, Toshiaki Ishida2, Daiichiro Hasegawa2, Keiichiro Kawasaki2, Seiji Yoshimoto3, Hideto Nakao3, Makiko Yoshida4, Yoshiyuki Kosaka2.   

Abstract

Congenital pure erythroid leukemia is exceedingly rare and poses a diagnostic challenge. We report an atypical case of congenital pure erythroid leukemia that did not express typical erythroid markers. The patient presented with a high white blood cell count with blastic cells at birth. Although flow cytometric analyses of peripheral blood and bone marrow showed a large CD45-negative cell population, we did not identify any evidence of monoclonality. While the circulating blasts decreased with only supportive care, hepatomegaly with multiple nodules was accompanied by liver failure, disseminated intravascular coagulation, and development of hemophagocytic lymphohistiocytosis. Pathological examination of the liver biopsy specimen revealed a small round cell tumor that was negative for nearly all hematopoietic cell markers, including classical erythroid cell markers, and positive for CD43, CD71, and E-cadherin, an early erythroid marker epithelial calcium-dependent adhesion protein, suggesting that these tumor cells originated from an immature erythroblast. We found high β-catenin and c-Myc protein expression, which were not previously described in pure erythroid leukemia. Cytosine arabinoside temporarily alleviated clinical symptoms; however, the patient died of progressive disease at 8 months of age. This case indicates that E-cadherin is useful for diagnosing pure erythroid leukemia, even in immature cases.

Entities:  

Keywords:  Congenital leukemia; Congenital pure erythroid leukemia; E-cadherin; Pure erythroid leukemia

Mesh:

Substances:

Year:  2017        PMID: 28523571     DOI: 10.1007/s12185-017-2248-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  27 in total

1.  Successful Treatment of Congenital Erythroleukemia With Low-Dose Cytosine Arabinoside.

Authors:  Gail C Halliday; John O'Reilly; Chloe Kelsey; Catherine H Cole; Rishi S Kotecha
Journal:  Pediatr Blood Cancer       Date:  2015-09-16       Impact factor: 3.167

Review 2.  Regulation of myelopoiesis by the transcription factor IRF8.

Authors:  Tomohiko Tamura; Daisuke Kurotaki; Shin-ichi Koizumi
Journal:  Int J Hematol       Date:  2015-03-07       Impact factor: 2.490

3.  Congenital erythroleukemia in a neonate with severe hypoxic ischemic encephalopathy.

Authors:  A Hadjiyannakis; W A Fletcher; D P Lebrun; R C van Wylick; K E Dow
Journal:  Am J Perinatol       Date:  1998       Impact factor: 1.862

4.  E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.

Authors:  Robert S Ohgami; Karen M Chisholm; Lisa Ma; Daniel A Arber
Journal:  Am J Clin Pathol       Date:  2014-05       Impact factor: 2.493

Review 5.  Acute erythroid leukemia.

Authors:  Zhuang Zuo; Jacek M Polski; Armen Kasyan; L Jeffrey Medeiros
Journal:  Arch Pathol Lab Med       Date:  2010-09       Impact factor: 5.534

Review 6.  Congenital leukaemia: the Dutch experience and review of the literature.

Authors:  Dorine Bresters; Angelino C W Reus; Anjo J P Veerman; Elizabeth R van Wering; Anna van der Does-van den Berg; Gertjan J L Kaspers
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

Review 7.  Congenital erythroleukemia: a case report with morphological, immunophenotypic, and cytogenetic findings.

Authors:  R R Allan; L D Wadsworth; D K Kalousek; B G Massing
Journal:  Am J Hematol       Date:  1989-06       Impact factor: 10.047

8.  Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA.

Authors:  A Nagafuchi; Y Shirayoshi; K Okazaki; K Yasuda; M Takeichi
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

9.  Congenital erythroleukemia. A case report.

Authors:  U Lasson; M Goos
Journal:  Blut       Date:  1981-10

10.  Congenital anerythremic erythroleukemia presenting as hepatic failure.

Authors:  Thierry Lazure; Anne Beauchamp; Laure Croisille; Sophie Ferlicot; Danielle Feneux; Monique Fabre
Journal:  Arch Pathol Lab Med       Date:  2003-10       Impact factor: 5.534

View more
  1 in total

1.  De novo primary central nervous system pure erythroid leukemia/sarcoma with t(1;16)(p31;q24) NFIA/CBFA2T3 translocation.

Authors:  Huifei Liu; Terri L Guinipero; Kathleen M Schieffer; Chris Carter; Susan Colace; Jeffrey R Leonard; Brent A Orr; Samir B Kahwash; Patrick J Brennan; James R Fitch; Benjamin Kelly; Vincent J Magrini; Peter White; Richard K Wilson; Elaine R Mardis; Catherine E Cottrell; Daniel R Boué
Journal:  Haematologica       Date:  2020-01-16       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.